CORT logoCORT
Corcept Therapeutics Inc

3,761
Loading...
Loading...
News
all
press releases
Can Korlym Drive Corcept's Growth Through the Rest of 2025?
CORT projects $850-$900M in 2025 revenues as Korlym sales rise and relacorilant nears an FDA decision for Cushing's syndrome.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?
CORT's stock is up 39.6% year to date as relacorilant nears FDA approval for Cushing's syndrome and expands into cancer studies.
Zacks·11d ago
News Placeholder
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
Corcept beats second-quarter earnings forecasts but misses the same for revenues. The company trims its 2025 revenue outlook.
Zacks·1mo ago
News Placeholder
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of +26.09% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?
Madrigal (MDGL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·2mo ago
News Placeholder
Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
CORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.
Zacks·2mo ago
News Placeholder
Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?
Style Box ETF report for XSMO
Zacks·2mo ago
News Placeholder
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?
Aurinia (AUPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·2mo ago
News Placeholder
Should JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE) Be on Your Investing Radar?
Zacks·3mo ago
News Placeholder
Should Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) Be on Your Investing Radar?
Zacks·3mo ago

Latest CORT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.